Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference26 articles.
1. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?;Finckh;Ann Rheum Dis,2010
2. Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis;Doan;J Manag Care Pharm,2006
3. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review;Rubbert-Roth;Arthritis Res Ther,2009
4. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study;Doran;Arthritis Rheum,2002
5. Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression;Connor;Rheumatol Int,2011
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Incidence of severe infection in patients with rheumatoid arthritis taking biologic agents: a systematic review;JBI Evidence Synthesis;2023-01-11
2. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics;Expert Review of Clinical Immunology;2020-01-11
3. Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score–Matched Cohort Study;Arthritis Care & Research;2019-11-29
4. Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study;Rheumatology;2019-11-25
5. The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis;Reumatismo;2019-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3